About 40 Mg Enoxaparin Sodium Injection IP
Highlighted for its invincible efficacy, the 40 Mg Enoxaparin Sodium Injection IP is a prescription-only anticoagulant highly recommended for the prevention and treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and acute coronary syndrome. Redeem mastery in patient care with its masterful subcutaneous administration, offering valuable support against clot formation. This clear, colorless to pale yellow solution boasts a shelf life of 24 months and is IP-certified, ensuring safety and regulatory compliance. Not for intramuscular usage; use cautiously in renal impairment. Suitable for adults, each pack contains a single pre-filled syringe.
Competitive Advantages & Application Areas
The 40 Mg Enoxaparin Sodium Injection IP stands out for its invincible reliability and swift action in prophylaxis and treatment of thromboembolic disorders. Highly recommended in hospitals, clinics, and surgical centers, this valuable medication ensures consistent outcomes for patients at risk of DVT, PE, or acute coronary syndrome. Its convenient pre-filled syringe facilitates effortless administration and enhances safety, making it a masterful choice for healthcare professionals managing cardiovascular complications.
Main Export Markets & Packing & Dispatch Details
Catering to global demand, the 40 Mg Enoxaparin Sodium Injection IP is exported to leading markets across Europe, Middle East, Africa, and Asia. Packing meets international standards with each syringe securely packed to preserve sterility and efficacy. Logistics are highly streamlined, ensuring rapid rate of dispatch and reliable delivery times tailored to distributor requirements. Each consignment is safely protected in light-resistant packaging, maintaining product integrity from source to destination.
FAQ's of 40 Mg Enoxaparin Sodium Injection IP:
Q: How should the 40 Mg Enoxaparin Sodium Injection IP be administered?
A: This injectable solution must be administered subcutaneously, typically once daily as directed by a physician. It is not suitable for intramuscular use.
Q: What conditions is this injection highly recommended for?
A: It is highly recommended for the prevention and treatment of deep vein thrombosis, pulmonary embolism, unstable angina, and non-Q wave myocardial infarction.
Q: When should I avoid using Enoxaparin Sodium Injection IP?
A: Avoid use if you have active major bleeding or a history of heparin-induced thrombocytopenia. Always consult a physician before starting therapy.
Q: Where is this product commonly applied?
A: This Masterful anticoagulant is widely used in hospitals, surgical setups, and clinics, for patients at elevated risk of thromboembolic events.
Q: What are the competitive advantages of this anticoagulant?
A: Its invincible action, IP certification, convenient single-use syringe, and masterful efficacy make it one of the most valuable choices for clinicians.
Q: How is the product exported and packed for international markets?
A: Each pre-filled syringe is rate packed in secure, light-resistant packaging, with logistics optimized for safe and prompt delivery to global destinations.